Literature DB >> 26970028

Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex.

Ravi S Shukla1, Akshay Jain1, Zhen Zhao1, Kun Cheng2.   

Abstract

Despite the importance of siRNA delivery systems, understanding of their intracellular fate remains elusive. We recently developed a multi-component siRNA nanocomplex to deliver siRNA to hepatic stellate cells (HSCs). The objective of this study is to study post-internalization trafficking of this siRNA nanocomplex and its multiple components like siRNA, protamine, and streptavidin, in HSCs. After internalization, the nanocomplex entrapped in early endosomes undergoes three possible routes including endosomal escape, exocytosis, and entrapment in lysosomes. Significant amount of siRNA dissociates from the nanocomplex to exert silencing activity. After escaping from endosomes, protamine dissociates from the nanocomplex and stays inside the cytoplasm. Golgi complex plays an important role in exocytosis of the nanocomplex. We also demonstrate that exocytosis is one of the major reasons accounting for the transient silencing activity of nonviral siRNA delivery. Incorporation of exocytosis inhibitors in nonviral siRNA delivery systems may extend the silencing activity of siRNA.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exocytosis; Hepatic stellate cells; Intracellular trafficking; Nanocomplex; siRNA delivery

Mesh:

Substances:

Year:  2016        PMID: 26970028      PMCID: PMC4889461          DOI: 10.1016/j.nano.2016.02.003

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  45 in total

Review 1.  Exocytosis of nanoparticles from cells: role in cellular retention and toxicity.

Authors:  Ramin Sakhtianchi; Rodney F Minchin; Ki-Bum Lee; Alaaldin M Alkilany; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Adv Colloid Interface Sci       Date:  2013-10-23       Impact factor: 12.984

2.  Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.

Authors:  Diego Delgado; Ana del Pozo-Rodríguez; Maria Ángeles Solinís; Alicia Rodríguez-Gascón
Journal:  Eur J Pharm Biopharm       Date:  2011-06-25       Impact factor: 5.571

3.  Development of siRNA-probes for studying intracellular trafficking of siRNA nanoparticles.

Authors:  Christopher A Alabi; Gaurav Sahay; Robert Langer; Daniel G Anderson
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

4.  TGF-beta1 gene silencing for treating liver fibrosis.

Authors:  Kun Cheng; Ningning Yang; Ram I Mahato
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

5.  Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.

Authors:  Yuhua Wang; Zhenghong Xu; Shutao Guo; Lu Zhang; Arati Sharma; Gavin P Robertson; Leaf Huang
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

6.  Development of cholesteryl peptide micelles for siRNA delivery.

Authors:  Bin Qin; Zhijin Chen; Wei Jin; Kun Cheng
Journal:  J Control Release       Date:  2013-08-19       Impact factor: 9.776

7.  Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.

Authors:  Jenny K W Lam; Wanling Liang; Yun Lan; Poulami Chaudhuri; Michael Y T Chow; Katarzyna Witt; Laila Kudsiova; A James Mason
Journal:  J Control Release       Date:  2011-11-26       Impact factor: 9.776

8.  A status report on RNAi therapeutics.

Authors:  Akshay K Vaishnaw; Jared Gollob; Christina Gamba-Vitalo; Renta Hutabarat; Dinah Sah; Rachel Meyers; Tony de Fougerolles; John Maraganore
Journal:  Silence       Date:  2010-07-08

9.  A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery.

Authors:  James J Lu; Robert Langer; Jianzhu Chen
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 10.  Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.

Authors:  Alfredo Erazo-Oliveras; Nandhini Muthukrishnan; Ryan Baker; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-01
View more
  18 in total

Review 1.  Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.

Authors:  R L Juliano
Journal:  Nucleic Acid Ther       Date:  2018-04-30       Impact factor: 5.486

Review 2.  The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.

Authors:  Akshay Jain; Kun Cheng
Journal:  J Control Release       Date:  2016-11-16       Impact factor: 9.776

3.  Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells.

Authors:  Zhen Zhao; Yuanke Li; Akshay Jain; Zhijin Chen; Hao Liu; Wei Jin; Kun Cheng
Journal:  Nanomedicine       Date:  2017-09-07       Impact factor: 5.307

4.  Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.

Authors:  Anna-Laurence Schachner-Nedherer; Oliver Werzer; Karin Kornmueller; Ruth Prassl; Andreas Zimmer
Journal:  Int J Nanomedicine       Date:  2019-09-25

5.  Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX.

Authors:  Zhijin Chen; Hao Liu; Akshay Jain; Li Zhang; Chang Liu; Kun Cheng
Journal:  Theranostics       Date:  2017-07-21       Impact factor: 11.556

6.  Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.

Authors:  Cuiling Zhang; Weigang Ren; Qingxin Liu; Zhikai Tan; Junwei Li; Chunyi Tong
Journal:  Drug Des Devel Ther       Date:  2019-04-04       Impact factor: 4.162

7.  ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications.

Authors:  Patricia Díaz-Saldívar; Juan Pablo Huidobro-Toro
Journal:  Int J Nanomedicine       Date:  2019-04-05

8.  Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.

Authors:  Mengchun Chen; Ledan Wang; Fang Wang; Fan Li; Weiliang Xia; Hongchen Gu; Yijie Chen
Journal:  Int J Nanomedicine       Date:  2019-05-15

9.  Tumor-Cell-Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody-Inhibitor Conjugates (AiCs).

Authors:  Andreas Faust; Nicole Bäumer; Alina Schlütermann; Manuel Becht; Lilo Greune; Christiane Geyer; Christian Rüter; Renato Margeta; Lisa Wittmann; Petra Dersch; Georg Lenz; Wolfgang E Berdel; Sebastian Bäumer
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-25       Impact factor: 16.823

Review 10.  Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.

Authors:  Md Emranul Karim; Kyi Kyi Tha; Iekhsan Othman; Mohammad Borhan Uddin; Ezharul Hoque Chowdhury
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.